| Product No. | CH063 |
|---|---|
| CAS Reg. No. | 124858-35-1 |
| Offer | 100 mg |
124858-35-1
- Documentation
- Details
9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid
Nadifloxacin (CAS Reg. No. 124858-35-1) is a high purity reference standard developed for demanding analytical applications. This reference material supports accurate quantification and reliable analytical performance. It is a reference standard produced and distributed by WITEGA Laboratorien Berlin-Adlershof GmbH, providing laboratories with consistent quality and traceable measurement results.
Nadifloxacin is widely used in LC-MS/MS and GC-MS analytical quantification workflows. Laboratories depend on this reference standard to establish accurate calibration curves and validate analytical methods. As a result, researchers and analysts can achieve reproducible data across multiple studies and sample matrices. In addition, the reference standard supports confirmatory analysis by enabling reliable identification and quantification of target compounds.
Traceability is essential in modern analytical laboratories. Therefore, this reference standard helps ensure confidence in measurement results and supports compliance with quality requirements. Furthermore, it contributes to method optimization and performance verification, making it a valuable tool for routine testing and advanced research projects.
Typical applications include pharmaceutical research, regulated laboratory testing, and residue control programs. Researchers use the reference standard during metabolism studies to investigate compound transformation and behavior. Moreover, it is suitable for multi-residue method development, allowing laboratories to evaluate analytical performance across a broad range of compounds. These capabilities make it an important resource for analytical scientists working with complex sample matrices.
- Suitable for LC-MS/MS and GC-MS analytical quantification
- Supports traceable calibration and method validation
- Enables accurate confirmatory analysis
- Applicable in pharmaceutical research laboratories
- Useful for residue control and metabolism studies
- Supports multi-residue method development
- Provides reliable analytical performance and consistency
By selecting this reference standard from WITEGA Laboratorien Berlin-Adlershof GmbH, laboratories can strengthen data quality, improve their workflow efficiency, and maintain confidence in analytical results.
Safety Data Sheet
You can download your Safety Data Sheet for CH063
For other languages please contact us: witega@witega.de
Additional information
| Molecular Weight | 360.39 g/mol |
|---|---|
| Chemical name | 9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid |
| Molecular Formula | C19H21FN2O4 |
| Isotopic purity | - |
| HPLC purity | 100 % |
| Overall purity | >98.0 % |
| Product Format | Neat |
| Delivery time | In stock |
| Shelf life | 24 months |
| Storage | Refrigerator, 2-8°C |
| Country of Origin | Germany |
| Product No. | |
| CAS Reg. No. | |
| Offer | 100 mg |
| MSDS_Deutsch | https://witega.de/wp-content/uploads/2026/06/CH063-Nadifloxacin-WITEGA-de.pdf |
| MSDS_English | https://witega.de/wp-content/uploads/2026/06/CH063-Nadifloxacin-WITEGA-en.pdf |
You may also like…
Ciprofloxacin-13C3,15N hydrochlorideCiprofloxacin 13C315N hydrochloride
CAS Reg. No.: 2483830-12-0





